Home

Features

Departments

News & Trends



 

TECHNOLOGY UPDATE

Edited by Michael Colvard, MD and Steven Charles, MD

An Update on 3-D Ultrasound


Will this new technology carve a niche in refractive surgery?

Walter Bethke,
Senior Editor


By spring of next year, refractive surgeons may have another option for measuring depth and irregularities of, not only the cornea, but also its individual layers as well as the LASIK flap. Here’s an update on some of the real-world applications of the Artemis 3-D Ultrasound.

The Artemis device sweeps a 50-MHz transducer in several arcs over the cornea. Then, a computer digitizes the signal and 3-D software interprets it, displaying such information as overall pachymetry, stromal thickness and residual stromal thickness post-LASIK down to a resolution of 1 µm.

Daniel Reinstein, MD, one of the device’s inventors, thinks the information the device imparts is vital to performing the best LASIK possible. He likens performing LASIK without the device to an orthopedic surgeon performing surgery without an X-ray.

“It can tell you how cutting a flap affects the shape of the cornea biomechanically,” he says. “It lets you predict how much tissue will be left under the flap, and why a patient may not be exactly perfect postop. The epithelium usually flows over irregularities, filling them. But, in some cases, it can’t compensate for them, and topography can’t measure it accurately, because the problem is below the surface.”

He cites the case of a patient he scanned in 1994 with the device. The wo-man had undergone a well-centered ALK but had some regression and triplopia. The corneal topography showed nothing unusual. The 3-D ultrasound, however, found a large irregularity in the stroma due to an irregular cut. “The epithelium had just about covered up the problem,” he says, “making the surface of the cornea look regular. Internally, however, she had multifocal optics.”

The Artemis may also have potential to stave off corneal ectasia, which some surgeons are reporting to be more common than they first thought.

Anyone who’s done a lot of LASIK cases has seen ectasia,” says Dr. Reinstein. He points out that the American Society of Cataract and Refractive Surgery devoted an entire section to ectasia this past year. “What if the flap you thought would be 160 µm turns out to be 220 µm? You may leave the cornea with only 190 µm, and you get ectasia.” With the device, the surgeon would be able to obtain a corneal thickness measurement at all points, not just the sampling done with normal pachymetry.

When phakic IOLs receive approval, the device will be able to give a sulcus-to-sulcus and angle-to-angle measurement in any meridian in 3-D. This may enable surgeons to reduce the risk of lens trauma and pupil ovalization that can occur if the IOL is incorrectly sized.

Some may wonder, however, if surgeons need such high-res imaging, at a cost of nearly $50,000, if LASIK outcomes already appear to be good.

“Surgery is the alteration of anatomy,” says Dr. Reinstein. “LASIK works very well and patients are happy. However, it behooves surgeons to adhere to, and not ignore, the basic tenet of ‘know the anatomy of the tissue on which you’re about to operate, and know the effects you will have on it.’ Now we have a diagnostic tool that will enable them to know exactly what happened.”

Artemis is still awaiting FDA 510(k) approval, which George Wiseman, president of the machine’s maker, Ultralink, expects by the second quarter of next year. “By the time we have them ready to ship, we should have our approval,” he says. 

Return to Features page